Abstract
Gentamicin is an aminoglycoside antibiotic widely used against infections caused by Gram-negative microorganisms. Nephrotoxicity is the main limitation to its therapeutic use. The objective of this study was to evaluate the potential protective effect of astaxanthin on the renal damage generated by gentamicin in rats, in an attempt to understand its mechanism of action, which may pave the way for possible therapeutic applications. The daily oral administration of the astaxanthin at a concentration of 50 mg/kg for 15 days to gentamicin (80 mg/kg.b.w) treated rats showed a significant decrease (p<0.05) in plasma creatinine, urea, TNF-α as well as plasma and renal MDA and HP. The treatment also resulted in a significant increase in hemoglobin, plasma sodium, potassium and TAS as well as renal total protein, GSH, Pr-SHs, G6PD, SOD, GPx, CAT and GR levels. The histological examinations of renal tissues in this study revealed damage and glomerular infiltration in gentamicin treated rats. The presented data suggest that astaxanthin has a significant prophylactic action against gentamicin-induced nephrotoxicity in rats. The effect was more pronounced in case of astaxanthin pre-treatment compared with administration of astaxanthin post-treatment. Taken together, astaxanthin has a potential as a protective and therapeutic agent for nephrotoxicity and deserves clinical trial in the near future as an adjuvant therapy in patients treated with gentamicin.
Keywords: Nephrotoxicity, gentamicin, astaxanthin, oxidative stress biomarkers and antioxidant.
Current Pharmaceutical Biotechnology
Title:Astaxanthin; a Promising Protector Against Gentamicin-Induced Nephrotoxicity in Rats
Volume: 17 Issue: 13
Author(s): Yasser O. Mosaad, Naglaa Abd El Khalik Gobba and Mohammed A. Hussein
Affiliation:
Keywords: Nephrotoxicity, gentamicin, astaxanthin, oxidative stress biomarkers and antioxidant.
Abstract: Gentamicin is an aminoglycoside antibiotic widely used against infections caused by Gram-negative microorganisms. Nephrotoxicity is the main limitation to its therapeutic use. The objective of this study was to evaluate the potential protective effect of astaxanthin on the renal damage generated by gentamicin in rats, in an attempt to understand its mechanism of action, which may pave the way for possible therapeutic applications. The daily oral administration of the astaxanthin at a concentration of 50 mg/kg for 15 days to gentamicin (80 mg/kg.b.w) treated rats showed a significant decrease (p<0.05) in plasma creatinine, urea, TNF-α as well as plasma and renal MDA and HP. The treatment also resulted in a significant increase in hemoglobin, plasma sodium, potassium and TAS as well as renal total protein, GSH, Pr-SHs, G6PD, SOD, GPx, CAT and GR levels. The histological examinations of renal tissues in this study revealed damage and glomerular infiltration in gentamicin treated rats. The presented data suggest that astaxanthin has a significant prophylactic action against gentamicin-induced nephrotoxicity in rats. The effect was more pronounced in case of astaxanthin pre-treatment compared with administration of astaxanthin post-treatment. Taken together, astaxanthin has a potential as a protective and therapeutic agent for nephrotoxicity and deserves clinical trial in the near future as an adjuvant therapy in patients treated with gentamicin.
Export Options
About this article
Cite this article as:
Mosaad O. Yasser, Gobba Abd El Khalik Naglaa and Hussein A. Mohammed, Astaxanthin; a Promising Protector Against Gentamicin-Induced Nephrotoxicity in Rats, Current Pharmaceutical Biotechnology 2016; 17 (13) . https://dx.doi.org/10.2174/1389201017666160922110740
DOI https://dx.doi.org/10.2174/1389201017666160922110740 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Acid Sensing Ion Channels and Acid Nociception
Current Pharmaceutical Design Central and Peripheral Expression and Distribution of NUCB2/nesfatin-1
Current Pharmaceutical Design Application of Chemoinformatic Tools for the Design of Novel Molecules as anti-Parkinsonian Agents
Current Signal Transduction Therapy Antifungal Therapy Used in Central Nervous System Fungal Infections
Central Nervous System Agents in Medicinal Chemistry Disaster Psychiatry: Good Intentions Seeking Science and Sustainability
Adolescent Psychiatry Update on the Medical Treatment of Allergic Rhinitis
Inflammation & Allergy - Drug Targets (Discontinued) Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer’s Disease in Mouse Model
Current Medicinal Chemistry Peripheral Kynurenine Metabolism in Focal Dystonia
Medicinal Chemistry Anticancer Natural Coumarins as Lead Compounds for the Discovery of New Drugs
Current Topics in Medicinal Chemistry Role of the GABAA Receptor in Anxiety: Evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies
Current Neuropharmacology Small Molecules ATP-Competitive Inhibitors of FLT3: A Chemical Overview
Current Medicinal Chemistry Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract
Current Neuropharmacology Structure-Activity Relationship Studies: Methods and Ligand Design for G-Protein Coupled Peptide Receptors
Current Protein & Peptide Science Repurposed Drugs in Metabolic Disorders
Current Topics in Medicinal Chemistry Physicochemical and Biological Aspects of Curcumin: A Review
The Natural Products Journal Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
Current Psychopharmacology Studying the Effects of Classic Hallucinogens in the Treatment of Alcoholism: Rationale, Methodology, and Current Research with Psilocybin
Current Drug Abuse Reviews Tackling Chronic Pain and Inflammation through the Purinergic System
Current Medicinal Chemistry The Nutrigenetics and Pharmacogenetics of Vitamin D Pathways
Current Pharmacogenomics and Personalized Medicine Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued)